Aldurazyme (Recombinant Human Alpha-L-Iduronidase)
ALID02205
Approved mab completed
Quick answer
Aldurazyme (Recombinant Human Alpha-L-Iduronidase) for Mucopolysaccharidosis I is a Approved program (mab) at BioMarin International Limited with 3 ClinicalTrials.gov record(s).
Program details
- Company
- BioMarin International Limited
- Indication
- Mucopolysaccharidosis I
- Phase
- Approved
- Modality
- mab
- Status
- completed